ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Early Treatment Versus Delayed Conservative Treatment of the Patent Ductus Arteriosus

ClinicalTrials.gov ID: NCT01958320

Public ClinicalTrials.gov record NCT01958320. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 20, 2026, 11:47 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Early Treatment Versus Delayed Conservative Treatment of the Patent Ductus Arteriosus in Preterm infants-a Multicenter Trial

Study identification

NCT ID
NCT01958320
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
University of California, San Francisco
Other
Enrollment
202 participants

Conditions and interventions

Interventions

  • NSAID Drug
  • no pharmacologic treatment of the PDA Other
  • pharmacologic treatment of the PDA Other

Drug · Other

Eligibility (public fields only)

Age range
5 Days to 14 Days
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 30, 2013
Primary completion
May 31, 2017
Completion
May 31, 2017
Last update posted
Nov 29, 2018

2013 – 2017

United States locations

U.S. sites
13
U.S. states
8
U.S. cities
12
Facility City State ZIP Site status
University of California San Diego San Diego California 92093-0934
Sharp Mary Birch Hospital for Women and Newborns San Diego California 92123
University of California San Francisco San Francisco California 94143
Mednax Neonatology of San Jose/Pediatrix Medical Group San Jose California 92868
Kaiser Permanente Santa Clara Santa Clara California 95051
South Miami Hospital Miami Florida 33143
University of Chicago Medicine Chicago Illinois 60637
Northshore University Health System Evanston Illinois 60201
Johns Hopkins University Baltimore Maryland 21218
Mayo Clinic Rochester Minnesota 55902
Morristown Medical Center Morristown New Jersey 07960
Columbia University New York New York 10032
Providence St Vincent Medical Center Portland Oregon 97225

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 5 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01958320, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 29, 2018 · Synced May 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01958320 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →